Floatz logo

FULVESTRANT

Neoplasms, Neuroepithelial

St. Jude Children's Research HospitalSmall moleculePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Neoplasms, Neuroepithelial cohort.

Asset / SponsorPhaseRating
Interleukin-12
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 1/2CCC
Dendritic Cell Tumor Fusion
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 1/2CCC
Sonidegib
St. Jude Children's Research Hospital
Phase 1CC
Letrozole
St. Jude Children's Research Hospital
Phase 1CC
Ribociclib
St. Jude Children's Research Hospital
Phase 1CC

View all 9 →

Same molecule, other indications

FULVESTRANT is also rated in:

Hormone Receptor Positive TumorDormant
BB
Indicative ·
70 / 100
View asset →
hormone receptor-positive breast cancerDormant
BB
Indicative ·
70 / 100
View asset →
Progesterone Receptor PositiveDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →